RNCOS

Global Gene Therapy Market Analysis

Press Release   •   Jul 12, 2012 12:31 IST

RNCOS has recently added a new Market Research Report titled, “Global Gene Therapy Market Analysis” to its report gallery. In the past few years, gene therapy has come a long way to become one of the most sought after methods to develop a treatment. Despite being at a nascent stage in terms of revenue generation, the gene therapy market holds tremendous growth potential. As per a new estimation, carried out in our latest study, the global gene therapy industry will reach US$ 325 Million by the end of 2015 as new products, especially those in the advanced stage of clinical studies or with pending approvals, may enter the market to boost the growth.

According to our new research report, “Global Gene Therapy Market Analysis”, major market players are developing gene therapy-based products using the adenoviral vectors. We found that the majority of the drugs using the adenoviral vectors are in the phase I/II clinical stages. In this context, the study provides a comprehensive overview of the different vectors in the gene therapy market, and talks about major products in the pipeline and their development phase.

Through in-depth and prudent analysis of the developments taking place at the global level, we have observed that the market is presently dominated by oncology applications. A large number of companies and academic institutions are developing products, targeting different types of cancer. Other therapeutic areas, such as genetic disorder and neurological diseases are also occupying enough space in the product pipeline. An effective analysis of the key therapeutic areas has been included in our report.

The report studies how trends and drivers, including gene silencing, advanced therapies and increased use of viral vectors, among others, will propel the industry’s growth. The study of key geographies revealed that the US, Europe, Canada, China, and Japan are the major markets exhibiting healthy growth rates. It also highlighted that the highest growth rate in the developing countries’ gene therapy market is likely to be observed for the treatment of cancer, followed by infectious diseases, like AIDS. Our comprehensive research report also looks into the profiles of key market players, including AnGes MG and Ark Therapeutics, to provide an objective view of the global gene therapy market to clients.

For FREE SAMPLE of this report visit: http://www.rncos.com/Report/IM282.htm

Some of our Related Reports are:

- Interferon Market Forecast to 2015 (http://www.rncos.com/Report/IM431.htm)
- Insulin Market Forecast to 2015 (http://www.rncos.com/Report/IM430.htm)
- Human Growth Hormone Market Forecast to 2015 (http://www.rncos.com/Report/IM429.htm)
- Erythropoietin Market Forecast to 2015 (http://www.rncos.com/Report/IM428.htm)

Check Related REPORTS on: http://www.rncos.com/Healthcare_Industry.htm

About RNCOS

RNCOS specializes in Industry intelligence and creative solutions for contemporary business segments. Our professionals analyze the industry and its various components, with a comprehensive study of the changing market behavior. Our accuracy and data precision proves beneficial in terms of pricing and time management that assist the intending consultants in meeting their objectives in a cost-effective and timely manner.